Video via Wongel Zelalem
Tonix will test its monkeypox vaccine in Kenya next year, and no eyes on accelerated path at FDA
The study of Tonix Pharmaceuticals’ live virus vaccine will occur at Kenya Medical Research Institute, or KEMRI, in the East African country, the partners said Thursday. While Kenya has no reported cases of the virus that leads to painful lesions, the country is close to the Democratic Republic of the Congo, which had 163 cases as of July 27, according to a CDC tracker.
Tonix has been working on monkeypox and smallpox for close to a decade, Lederman said. The company’s vaccine, dubbed TNX-801, is traced back to a research collaboration with the Department of Cell Biology at the University of Alberta.
Read More »
Why America Doesn’t Trust the CDC
Most remarkably, it didn’t seem to matter to the CDC that 75.2 percent of children under age 11 already have natural immunity, according to a CDC study that concluded in February. Natural immunity is certainly much more prevalent today, given the ubiquity of the Omicron variant since February. CDC data from New York and California demonstrated that natural immunity was 2.8 times more effective in preventing hospitalization and 3.3 to 4.7 times more effective in preventing COVID infection compared to vaccination during the Delta wave. These findings are consistent with dozens of other clinical studies. Yet natural immunity has consistently and inexplicably been dismissed by the medical establishment.
Public health officials are expected to recommend COVID vaccines for children under 5 as soon as June 21st, despite the fact that the vast majority of children already have natural immunity. In a recent Kaiser survey, only 18 percent of parents said they were eager to vaccinate their child in that age group.
Rat Out Your Doctor: Biden’s Surgeon General Calls on Informants to Report Use of Generic Drugs
The purpose of the RFI is described as being to help the authorities understand the effect of pandemic “misinformation” on such areas as “health decisions and outcomes, direct and indirect costs, trust in the healthcare system and providers, and healthcare worker morale and safety. It is also intended to help them ascertain its impact on “access to trusted and credible health information, particularly during a public health emergency” and on “lifesaving health decisions such as an individual’s likelihood to vaccinate, and to “prepare for and respond to future public health crises.”
The RFI, which covers a period extending from January 2020 to the present, applies to general search engines, content sharing platforms, social media platforms, e-commerce platforms, crowd-sourced platforms, and instant messaging systems, and includes “research, case studies, data sets, images, data visualizations, interviews, and personal testimonies.”
FDA is considering FOURTH dose of COVID-19 vaccine and making it an annual shot as cases across the US drop 43% over the past week and 87% since the peak of the Omicron variant
WSJ: FDA Eyes Second Covid-19 Booster Shot
A fourth booster shot of either the Pfizer or Moderna vaccine could start an annual booster shot campaign, one of the people familiar with the FDA’s planning said.
I’m not buying the media’s scaremongering about the second omicron variant!